[1]
N. Kimura, “Upfront Androgen Receptor-Axis-Targeted Therapies in Men with De Novo High-Volume Metastatic Hormone-Sensitive Prostate Cancer”, Urol J, vol. 20, no. 04, pp. 222–228, Jul. 2023.